Rossmore Private Capital’s Novo Nordisk NVO Stock Holding History

Rossmore Private Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Hold	23,000	–	–	0.09%	149
2026 Q1	$873K	Sell	23,000 -700	-3%	-$33.2K	0.08%	156
2025 Q4	$1.21M	Buy	23,700 +700	+3%	+$35.8K	0.11%	131
2025 Q3	$1.28M	Hold	23,000	–	–	0.14%	117
2025 Q2	$1.59M	Sell	23,000 -305	-1%	-$20.7K	0.19%	95
2025 Q1	$1.62M	Buy	23,305 +112	+0.5%	+$9.25K	0.2%	87
2024 Q4	$2M	Buy	23,193 +38	+0.2%	+$4.11K	0.25%	80
2024 Q3	$2.76M	Buy	23,155 +155	+0.7%	+$20.7K	0.34%	62
2024 Q2	$3.28M	Hold	23,000	–	–	0.43%	53
2024 Q1	$2.95M	Hold	23,000	–	–	0.39%	58
2023 Q4	$2.38M	Hold	23,000	–	–	0.34%	65
2023 Q3	$2.09M	Hold	23,000	–	–	0.32%	67
2023 Q2	$1.86M	Hold	23,000	–	–	0.28%	74
2023 Q1	$1.83M	Hold	23,000	–	–	0.29%	71
2022 Q4	$1.56M	Hold	23,000	–	–	0.25%	80
2022 Q3	$1.15M	Hold	23,000	–	–	0.21%	89
2022 Q2	$1.28M	Hold	23,000	–	–	0.22%	89
2022 Q1	$1.28M	Hold	23,000	–	–	0.2%	95
2021 Q4	$1.29M	Hold	23,000	–	–	0.2%	98
2021 Q3	$1.1M	Hold	23,000	–	–	0.19%	102
2021 Q2	$963K	Hold	23,000	–	–	0.16%	111
2021 Q1	$775K	Hold	23,000	–	–	0.15%	117
2020 Q4	$803K	Hold	23,000	–	–	0.16%	110
2020 Q3	$798K	Hold	23,000	–	–	0.19%	103
2020 Q2	$753K	Hold	23,000	–	–	0.21%	99
2020 Q1	$692K	Hold	23,000	–	–	0.24%	90
2019 Q4	$666K	Hold	23,000	–	–	0.21%	79
2019 Q3	$595K	Hold	23,000	–	–	0.2%	80
2019 Q2	$587K	Hold	23,000	–	–	0.21%	80
2019 Q1	$602K	Hold	23,000	–	–	0.22%	78
2018 Q4	$530K	Hold	23,000	–	–	0.22%	76
2018 Q3	$542K	Buy	+23,000	New	+$561K	0.22%	75
2018 Q1	–	Sell	-860	Closed	-$23.1K	–	305
2017 Q4	$23.1K	Buy	+860	New	+$21.9K	0.02%	239

Other funds holding NVO

SRIM

Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return

Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

AIIMS

Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Rossmore Private Capital's NVO Position: Q2 2026 in Review

Rossmore Private Capital held its Novo Nordisk (NVO) position steady in Q2 2026 at 23,000 shares worth $1.1M. The position accounts for 0.09% of the portfolio, ranked #149.

Rossmore Private Capital first reported a position in NVO in Q4 2017 and has held it in 33 quarters since. The position peaked at $3.28M in Q2 2024. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Rossmore Private Capital held 23,000 shares of Novo Nordisk worth $1.1M as of Q2 2026.
Rossmore Private Capital left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.09% of Rossmore Private Capital's portfolio in Q2 2026, its #149 holding.
Rossmore Private Capital first reported a position in Novo Nordisk in Q4 2017 and has held it in 33 quarters since.
Rossmore Private Capital's Novo Nordisk position peaked at $3.28M in Q2 2024.
580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.